These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32870904)

  • 21. Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
    Verhenne S; Vandeputte N; Pareyn I; Izsvák Z; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):836-844. PubMed ID: 28254814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling ADAMTS13-von Willebrand factor interaction: Implications for oxidative stress-related cardiovascular diseases and type 2A von Willebrand disease.
    Pozzi N; Lancellotti S; De Cristofaro R; De Filippis V
    Biophys Chem; 2012 Jan; 160(1):1-11. PubMed ID: 21937160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
    Sonneveld MA; de Maat MP; Leebeek FW
    Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional correlation of ADAMTS13.
    Dong JF
    Curr Opin Hematol; 2007 May; 14(3):270-6. PubMed ID: 17414218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
    Song J; Lee KA; Park TS; Park R; Choi JR
    Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases.
    Ko S; Okano E; Kanehiro H; Matsumoto M; Ishizashi H; Uemura M; Fujimura Y; Tanaka K; Nakajima Y
    Liver Transpl; 2006 May; 12(5):859-69. PubMed ID: 16528712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.
    Casonato A; Pontara E; Battiston M; Morpurgo M; Cattini MG; Casarin E; Saga G; Daidone V; De Marco L
    Thromb Haemost; 2013 Jun; 109(6):999-1006. PubMed ID: 23446343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
    Löwenberg EC; Charunwatthana P; Cohen S; van den Born BJ; Meijers JC; Yunus EB; Hassan MU; Hoque G; Maude RJ; Nuchsongsin F; Levi M; Dondorp AM
    Thromb Haemost; 2010 Jan; 103(1):181-7. PubMed ID: 20062916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.
    Yagi H; Yamaguchi N; Shida Y; Sugimoto M; Tubaki K; Fujimura Y; Matsumoto M
    Thromb Res; 2017 Nov; 159():91-95. PubMed ID: 29040872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Platelet-independent adhesion of calcium-loaded erythrocytes to von Willebrand factor.
    Smeets MWJ; Bierings R; Meems H; Mul FPJ; Geerts D; Vlaar APJ; Voorberg J; Hordijk PL
    PLoS One; 2018; 13(3):e0194958. PubMed ID: 29561911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS13-von Willebrand factor axis is involved in the pathophysiology of kidney ischaemia-reperfusion injury.
    Kim MG; Lim SY; Ko YS; Lee HY; Jo SK; Cho WY
    Nephrology (Carlton); 2017 Nov; 22(11):913-920. PubMed ID: 27507004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
    Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
    Schneppenheim R; Budde U
    Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.